Author

Warren Bao

Institution: Pfizer (United States)

Observed institutions: Brigham and Women's Hospital, Cleveland Clinic, State University of New York, The University of Melbourne, Pfizer (United States), Baylor College of Medicine, Montreal Heart Institute, Austin Health, Imperial College London

OpenAlex ID: A5060074170

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

2004 · Stephen B Hanauer, Carrie L Wagner, et al. · Clinical Gastroenterology and Hepatology · 603

Assessing performance of sequential analysis methods for active drug safety surveillance using observational data

2017 · Xiaofeng Zhou, Warren Bao, et al. · Journal of Biopharmaceutical Statistics · 5

Response to Chadi A. Calarge re: “Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)”

2024 · Francesca Kolitsopoulos, Sara Ramaker, et al. · Journal of Child and Adolescent Psychopharmacology · 1

Acute Pancreatitis With Long-Term Celecoxib VS. Ibuprofen or Naproxen: Data From the PRECISION Trial

2018 · Neville D. Yeomans, David Y. Graham, et al. · The American Journal of Gastroenterology · 1

P2-4 Safety of Atorvastatin in Asian Patients Within Clinical Trials

2007 · Warren Bao, Elizabeth DaSilva, et al. · International Journal of Cardiology · 1

Clinical Determinants of Incident Aortic Stenosis in Statin–treated Stable Coronary Patients

2013 · Benoit Arsenault, Matthijs Boekholdt, et al. · Journal of the American College of Cardiology

Regardless of duration of corticosteroid treatment, infliximab (REMICADE) maintenance therapy enables steroid elimination: ACCENT I experience

2003 · Gary R. Lichtenstein, Allan Olson, et al. · Gastroenterology

Works count: 7

Citation count: 611

H-index: 2

I10-index: 1